Pharmacy

The investigation is spurred by dramatic drug price increases, often on older, off-patent drugs, after the acquisition or merger of pharmaceutical companies.

Healthcare spending grew by 3.4 percent in 2014, a new report by the Health Care Cost Institute found, even though overall utilization declined.

Pharmaceutical manufacturer Warner Chilcott will plead guilty and pay $125 million after admitting to paying kickbacks to doctors and other healthcare professionals so they would prescribe drugs Actonel, Asacol, Atelvia, Doryx, Enablex, Estrace, Loestrin and others, the U.S. Department of Justice announced Thursday.

Menlo Park, California-based Frazier Healthcare Partners has closed on a $262 investment fund that it plans to use to back biomedical companies developing new therapeutics products.

Pharmaceutical giant Pfizer is reportedly poised to buy Botox-maker Allergan, in what would be one of the biggest takeover deal this year, according to The Wall Street Journal.

Rite Aid has worked to expand its RediClinics, walk-in health centers, while Walgreens has aggressively expanded its walk-in clinic business.

Turing Pharmaceuticals chief Martin Shkreli will face new competition for Daraprim, the AIDS drug he recently hiked 5,000 percent in price, after competitor Imprimis Pharmaceuticals on Thursday said it will market a similar drug for just $1 a tablet.

The medication therapy management model is being tested in five regions as an incentive to boost adherence for stand-alone Part D plans not connected with Medicare Advantage.

America's Health Insurance Plans on Wednesday called former Secretary of State Hillary Clinton's stance against major insurance company consolidation misguided, and suggested that the presidential candidate focus on other issues plaguing healthcare instead.

Nearly every C-suite respondent to Premier's 2015 Economic Outlook said pharmaceutical price increases are their top area of concern.